These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6540163)

  • 1. [The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy].
    Guo HS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Mar; 12(1):13-6. PubMed ID: 6540163
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy].
    Zhao ZL
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):439-41. PubMed ID: 6685611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of verapamil on left ventricular function and exercise tolerance in hypertrophic cardiomyopathic patients].
    Zeng XH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Sep; 11(3):198-201. PubMed ID: 6686519
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy].
    Wang AA; Gu FS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):25-6. PubMed ID: 3608781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy].
    Dabrowski M; Górecka B; Witkowski A; Jodkowski J; Woroszylska M; Ruzyłło W
    Kardiol Pol; 1986; 29(5-6):345-55. PubMed ID: 3784250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].
    Kaltenbach M; Hopf R; Keller M
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1284-7. PubMed ID: 8298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of verapamil on the left ventricular diastolic function and diastolic asynchrony in patients with hypertrophic cardiomyopathy].
    Emoto R; Yokota Y; Miki T; Usuki S; Miki T; Nomura H; Takeuchi Y; Nakatani M; Fukuzaki H
    J Cardiol; 1991; 21(1):87-96. PubMed ID: 1817184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cas Lek Cesk; 1987 Mar; 126(11):330-4. PubMed ID: 3829106
    [No Abstract]   [Full Text] [Related]  

  • 10. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does verapamil affect the thickness of the cardiac muscle in hypertrophic cardiomyopathy?].
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Vnitr Lek; 1986 Dec; 32(12):1188-96. PubMed ID: 3824918
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: an overview.
    Epstein SE; Maron BJ
    Clin Invest Med; 1980; 3(1-2):185-93. PubMed ID: 7008999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L; Hess OM; Grimm J; Krayenbühl HP
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of verapamil in the treatment of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Vísek V; Sládková T; Dvorák J
    Cor Vasa; 1986; 28(6):404-12. PubMed ID: 3829686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Doppler evaluation of left ventricular diastolic filling after intravenous injection of verapamil in patients with hypertrophic cardiomyopathy].
    Jin L; Zhu WL; Mu JL
    Zhonghua Nei Ke Za Zhi; 1988 Jul; 27(7):412-4, 454. PubMed ID: 3064997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.